🔎 Trials Near Me

Dachaigh › Galar cealla corraich › Alabama

Sgrùdaidhean clionaigeach Galar cealla corraich ann an Alabama

Tha 16 sgrùdaidhean airson Galar cealla corraich a’ lorg phàirtichean aig làraichean ann an Alabama.

Bailtean ann an Alabama

Teacsa sgrùdaidh oifigeil (Beurla)

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07187973

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Uni of Alabama at Birmingham, Birmingham
  • Univer South Alabama Ped/Onc, Mobile
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • University of Alabama Birmingham, Birmingham
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 12 gu 55 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06546670

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

  • University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06442761

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • AMR Clinical, Mobile
A’ fastadhÌre 2/3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT05431088

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06481306

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A’ fastadhÌre 3
Aoisean 10 gu 65 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06975865

Early Life Exposures Among Children With Sickle Cell Disease

  • University of Alabama at Birmingham, Birmingham
A’ fastadh
Aoisean 18 gu 50 · Banairean · Air ùrachadh 15 Iuch 2026 · NCT05377372

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  • University Of Alabama, Birmingham
A’ fastadhÌre 4
6 Months – 100 Years · Gach gnè · Air ùrachadh 8 Ògmh 2026 · NCT04657822

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's of Alabama (MRD-HCT), Birmingham
  • Children's of Alabama (NT-DMT), Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 3 gu 20 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06941389

Cognitive Remediation Intervention to Prepare for Transition of Care

  • University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 2
Aoisean 10 gu 18 · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT05336201

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • University of Alabama at Birmingham, Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 14 gu 37 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT07373639

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • University of South Alabama Medical Center, Mobile
A’ fastadh
Aoisean 16 gu 30 · Gach gnè · Air ùrachadh 7 Faoi 2026 · NCT06374238

HPC Offered for PRESERVE Expansion

  • University of Alabama, Birmingham, Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 12 gu 80 · Gach gnè · Air ùrachadh 28 Lùna 2025 · NCT07145411

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Alabama, Birmingham (UAB), Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2025 · NCT06385886

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.